Inverse relation between severity of psoriasis and serum 1,25-dihydroxyvitamin D level
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 1 (4) , 277-282
- https://doi.org/10.1016/0923-1811(90)90120-3
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (63570505)
This publication has 17 references indexed in Scilit:
- A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisJournal of the American Academy of Dermatology, 1988
- Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind studyBritish Journal of Dermatology, 1988
- 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation.Journal of Clinical Investigation, 1986
- Topical administration of 1,25-dihydroxyvitamin D3 for proriasis: Report of five casesCalcified Tissue International, 1986
- 1α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cellsBiochemical and Biophysical Research Communications, 1981
- THE EFFECT OF OESTROGENS ON HUMAN CALCITONIN SECRETION AFTER CALCIUM INFUSION IN ELDERLY FEMALE SUBJECTSClinical Endocrinology, 1980
- [55] Competitive protein binding assay for plasma 25-hydroxycholecalciferolPublished by Elsevier ,1980
- Psoriasis exacerbated by hypoparathyroidism with hypocalcaemiaBritish Journal of Dermatology, 1973
- Abnormal Cell Proliferation in Psoriasis**From the Department of Dermatology, University of Miami School of Medicine, Miami, Florida.Journal of Investigative Dermatology, 1968
- PseudohypoparathyroidismA.M.A. Archives of Dermatology, 1959